1. Summary Information
|
|
|
Country |
|
|
Company Name |
NEON LABORATORIES LIMITED |
Principal Name 1 |
Mr. Uttam Keshrimal Jain |
|
Status |
Good |
Principal Name 2 |
Mr. Pravin Keshrimal Jain |
|
|
|
Registration # |
11-027493 |
|
Street Address |
140, Damji
Shamji Industrial Complex, |
||
|
Established Date |
22.06.1982 |
SIC Code |
-- |
|
Telephone# |
91-22-26875366 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-22-26873502 |
Business Style 2 |
Trader |
|
Homepage |
Product Name 1 |
Injections |
|
|
# of employees |
1000
(Approximately) |
Product Name 2 |
Tablets/Capsules/Supstry |
|
Paid up capital |
Rs.15,300,000 /- |
Product Name 3 |
Syrup Bottles Saches |
|
Shareholders |
Directors or relatives of Directors - 99.91
% Other - 0.09% |
Banking |
State
Bank of India |
|
Public Limited Corp. |
NO |
Business Period |
30 Year |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
A
(60) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Subsidiaries |
India |
VHB Life Sciences Limited |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2011 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
1,830,759,000 |
Current Liabilities |
620,598,000 |
|
Inventories |
166,993,000 |
Long-term Liabilities |
555,791,000 |
|
Fixed Assets |
576,476,000 |
Other Liabilities |
256,339,000 |
|
Deferred Assets |
0,000 |
Total Liabilities |
1,432,728,000 |
|
Invest& other Assets |
303,891,000 |
Retained Earnings |
1,430,091,000 |
|
|
|
Net Worth |
1,445,391,000 |
|
Total Assets |
2,878,119,000 |
Total Liab. & Equity |
2,878,119,000 |
|
Total Assets (Previous Year) |
1,693,093,000 |
|
|
|
P/L Statement as of |
31.03.2011 |
(Unit: Indian Rs.) |
|
|
Sales |
2,040,772,000 |
Net Profit |
405,819,000 |
|
Sales(Previous yr) |
1,468,545,000 |
Net Profit(Prev.yr) |
280,297,000 |
MIRA
INFORM REPORT
|
Report Date : |
31.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
NEON LABORATORIES LIMITED |
|
|
|
|
Registered
Office : |
140, Damji Shamji Industrial Complex, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of Incorporation
: |
22.06.1982 |
|
|
|
|
Com. Reg. No.: |
11-027493 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.15.300
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24100MH1982PCL027493 |
|
|
|
|
TAN No.: [Tax Deduction & Collection
Account No.] |
MUMN11047B / MUMN10021E |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACN1299D |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company. |
|
|
|
|
Line of Business
: |
Manufacturer and Trader Pharmaceutical and Healthcare Products. |
|
|
|
|
No. of Employees
: |
1000 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
A (60) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 5700000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having fine track. Financial
position of the company appears to be sound. Trade relations are reported as fair.
Business is active. Payments are reported to be regular and as per
commitments. The company can be considered good for normal business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION DENIED BY
|
Name : |
Mr. Rakesh Parmar |
|
Designation : |
Finance Executive |
|
Contact No.: |
91-22-26875366 |
|
Date : |
19.03.2012 |
LOCATIONS
|
Registered Office / Corporate Office : |
140, Damji Shamji Industrial Complex, Mahakali Caves Road, Andheri, Mumbai-
400093, Maharashtra, India |
|
Tel. No.: |
91-22-26875366 / 72/ 30077000 |
|
Fax No.: |
91-22-26873502 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
800 Sq. Ft |
|
Location : |
Owned |
DIRECTORS
As on 27.09.2011
|
Name : |
Mr. Uttam Keshrimal Jain |
|
Designation : |
Director |
|
Address : |
2005 |
|
Date of Birth/Age : |
05.02.1954 |
|
Date of Appointment : |
22.06.1982 |
|
DIN No.: |
00205866 |
Other Directorship:
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U24100MH1982PLC027493 |
NEON
LABORATORIES LIMITED |
Director |
22-06-82 |
22-06-82 |
- |
Active |
NO |
|
2 |
U24230MH2004PTC147834 |
METREX
PHARMACEUTICALS PRIVATE LIMITED |
Director |
03-08-04 |
03-08-04 |
- |
Active |
NO |
|
3 |
U24233DL2005PLC140455 |
UTTARANCHAL
BIOTECH LIMITED |
Director |
22-09-08 |
24-03-08 |
- |
Active |
NO |
|
4 |
U24231GJ2003PTC042925 |
SIENNA
FORMULATIONS PRIVATE LIMITED |
Director |
11-02-09 |
11-02-09 |
- |
Active |
NO |
|
Name : |
Mr. Pravin Keshrimal Jain |
|
Designation : |
Director |
|
Address : |
201- 201A |
|
Date of Birth/Age : |
18.03.1964 |
|
Date of Appointment : |
06.02.1996 |
|
DIN No.: |
00205927 |
Other Directorship:
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U24100MH1982PLC027493 |
NEON
LABORATORIES LIMITED |
Director |
06-02-96 |
06-02-96 |
- |
Active |
NO |
|
2 |
U24233DL2005PLC140455 |
UTTARANCHAL
BIOTECH LIMITED |
Director |
22-09-08 |
24-03-08 |
- |
Active |
NO |
|
3 |
U24231GJ2003PTC042925 |
SIENNA
FORMULATIONS PRIVATE LIMITED |
Director |
11-02-09 |
11-02-09 |
- |
Active |
NO |
|
Name : |
Mr. Abhay Uttam Jain |
|
Designation : |
Additional Director |
|
Address : |
2005 |
|
Date of Birth/Age : |
17.04.1984 |
|
Date of Appointment : |
05.02.2007 |
|
DIN No.: |
01304069 |
Other Directorship:
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U24230MH1990PTC057496 |
NAPROD
LIFE SCIENCES PRIVATE LIMITED |
Director |
03-02-07 |
03-02-07 |
- |
Dormant |
NO |
|
2 |
U24100MH1982PLC027493 |
NEON
LABORATORIES LIMITED |
Additional
director |
05-02-07 |
05-02-07 |
- |
Active |
NO |
|
3 |
U24233DL2005PLC140455 |
UTTARANCHAL
BIOTECH LIMITED |
Director |
22-09-08 |
22-09-08 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. Mukesh Surajimal Jain |
|
Designation : |
Secretary |
|
Address : |
1-110 Mhada, Mahakali Caves Road, Andheri East, Mumbai- 400093,
Maharashtra, India |
|
Date of Birth/Age : |
28.06.1971 |
|
Date of Appointment : |
01.07.1997 |
|
|
|
|
Name : |
Mr. Rakesh Parmar |
|
Designation : |
Finance Executive |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 27.09.2011
|
Names of Shareholders |
|
No. of Shares |
|
Babulal Keshrimal Jain |
|
43604 |
|
Uttam Keshrimal Jain |
|
36263 |
|
Ashok Keshrimal Jain |
|
99050 |
|
Pravin Keshrimal Jain |
|
40632 |
|
|
|
113287 |
|
Kamla B. Jain |
|
129297 |
|
Meena A. Jain |
|
121917 |
|
Moham B. Jain |
|
39044 |
|
Manohar D. Sirsankar |
|
1333 |
|
Manish B. Jain |
|
8820 |
|
Uttam Keshrimal Jain (HUF) |
|
104850 |
|
Babula Keshrimal Jain (HUF) |
|
25713 |
|
Pravin Jain – Hira and Company, |
|
67 |
|
Ashok Keshrimal Jain (HUF) |
|
64400 |
|
Bharti P. Jain |
|
161333 |
|
Rohan A. Jain |
|
56802 |
|
|
|
128743 |
|
Rahul A. Jain |
|
86101 |
|
Prachi P. Jain |
|
92270 |
|
Manish B. Jain (HUF) |
|
5867 |
|
Pravin Keshrimal Jain (HUF) |
|
33090 |
|
Sangeeta M. Jain |
|
111757 |
|
Aarya M. Jain |
|
100 |
|
Misal P. Jain |
|
100 |
|
Niyati P. Jain |
|
1450 |
|
Mohan B. Jain (HUF) |
|
24110 |
|
Total |
|
1530000 |
As on 27.09.2011
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage |
|
Directors or relatives of Directors |
99.91 |
|
Other |
0.09 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Trader Pharmaceutical and Healthcare Products. |
||||||||||
|
|
|
||||||||||
|
Products : |
· Anaesthetics and Allied Products · Antineoplast Product · Corticosteroids and Hormons Products · Antibacterials Products · Antitubercular Product · Gynaecological Products · Analgesic and Antipyratic Product · Cardiovascular Products · Vitamin, Haematinic and Mineral Preparations · Antihistamine, Cough and Cold Preparation · Other Specialities ·
Vetrinary Products ·
|
GENERAL INFORMATION
|
No. of Employees : |
1000 (Approximately) |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Bankers : |
State Bank of |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Facilities : |
(Rs. In
Millions)
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Nikhil Gandhi and Company Chartered Accountant |
|
Address : |
303-304, Vyom Arcade, Tejpal Scheme Road No. 5, Vile Parle (East),
Mumbai – 400057, Maharashtra, India |
|
Tel. No.: |
91-22-66981760 / 26205279 |
|
Fax No.: |
91-22-66981760 |
|
PAN.: |
AABPG4149D |
|
|
|
|
Subsidiaries : |
(CIN No. : U74900MH2007PLC171648)
(CIN No. : U24232MH2007PLC174054) |
CAPITAL STRUCTURE
As on 27.09.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
4000000 |
Equity Shares |
Rs.10/- each |
Rs.40.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1530000 |
Equity Shares |
Rs.10/- each |
Rs.15.300
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
15.300 |
15.300 |
15.300 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
1430.091 |
1030.684 |
753.606 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
1445.391 |
1045.984 |
768.906 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
403.454 |
87.626 |
10.709 |
|
|
2] Unsecured Loans |
152.337 |
59.931 |
59.931 |
|
|
TOTAL BORROWING |
555.791 |
147.557 |
70.64 |
|
|
DEFERRED TAX LIABILITIES |
53.138 |
40.753 |
16.799 |
|
|
|
|
|
|
|
|
TOTAL |
2054.320 |
1234.294 |
856.345 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
576.476 |
463.086 |
189.523 |
|
|
Capital work-in-progress |
0.000 |
63.194 |
162.987 |
|
|
|
|
|
|
|
|
INVESTMENT |
303.891 |
26.074 |
12.694 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
166.993
|
180.006
|
185.102 |
|
|
Sundry Debtors |
443.745
|
205.457
|
226.071 |
|
|
Cash & Bank Balances |
5.227
|
0.863
|
0.568 |
|
|
Other Current Assets |
0.000
|
0.000
|
0.000 |
|
|
Loans & Advances |
1381.787
|
754.413
|
486.997 |
|
Total
Current Assets |
1997.752
|
1140.739 |
898.738 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
486.828
|
254.260 |
210.817 |
|
|
Other Current Liabilities |
133.770
|
74.336
|
64.974 |
|
|
Provisions |
203.201
|
130.203
|
131.806 |
|
Total
Current Liabilities |
823.799
|
458.799 |
407.597 |
|
|
Net Current Assets |
1173.953
|
681.940
|
491.141 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
2054.320 |
1234.294 |
856.345 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Operating Income |
2040.772 |
1468.545 |
1356.570 |
|
|
|
Other Income |
54.398 |
62.959 |
35.033 |
|
|
|
TOTAL (A) |
2095.170 |
1531.504 |
1391.603 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Consumption materials changes inventories |
632.395 |
533.183 |
|
|
|
|
Manufacturing service costs |
114.040 |
97.907 |
|
|
|
|
Employee related expenses |
227.275 |
166.549 |
1027.285 |
|
|
|
Administrative selling other expenses |
432.291 |
259.919 |
|
|
|
|
Research development expenditure |
12.432 |
7.064 |
|
|
|
|
TOTAL (B) |
1418.433 |
1064.622 |
1027.285 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
676.737 |
466.882 |
364.318 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
30.237 |
11.851 |
8.837 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
646.500 |
455.031 |
355.481 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
28.296 |
20.456 |
9.597 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
618.204 |
434.575 |
345.884 |
|
|
|
|
|
|
|
|
|
Less |
TAX (I) |
212.385 |
154.278 |
135.042 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) (J) |
405.819 |
280.297 |
210.842 |
|
|
|
|
|
|
|
|
|
Add/ Less |
INCOME
TAX FOR EARLIER YEARS |
0.000 |
0.000 |
0.030 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
45.000 |
9.000 |
9.000 |
|
|
|
Interim Dividend |
2.754 |
2.066 |
2.065 |
|
|
|
Final Dividend |
2.754 |
0.688 |
0.688 |
|
|
|
Tax on Dividend |
0.904 |
0.465 |
0.468 |
|
|
BALANCE CARRIED
TO THE B/S |
354.407 |
268.078 |
198.651 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
NA |
95.617 |
106.049 |
|
|
TOTAL EARNINGS |
NA |
95.617 |
106.049 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
NA |
178.134 |
162.091 |
|
|
|
Capital Goods |
NA |
18.354 |
46.819 |
|
|
TOTAL IMPORTS |
NA |
196.488 |
208.91 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
265.29 |
183.20 |
137.02 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
19.37
|
18.30 |
15.15 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
30.29
|
29.59 |
24.86 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
24.02
|
27.10 |
31.78 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.42
|
0.42 |
0.45 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.95
|
0.58
|
0.62 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.43
|
2.49
|
2.20 |
LOCAL AGENCY FURTHER INFORMATION
OPERATION
The company s Sales Turnover during the year has registered a growth of 38 over previous Financial Year. That is Sales Turnover for F.Y.10-11 stands Rs.2040.000 Millions that from Rs.1470.000 Millions as compared to last Financial Year. Despite age increase of Interest burdon that from 0.25 in F.Y.09-10 to 0.41 in F.Y.10-11, other operational cost have been kept under control by The Director resulting thereby increased Profitability of Rs.61.820.000 Millions in F.Y.10-11 that from Rs.43.460.000 Millions in the Previous Financial Year. Further, the company s sales and profitability have been growing from year to year under the able guidance of the Board and Board of The Company is confident of maintaining the momentum of growth in the years to come.
CONTINGENT LIABILITIES NOT PROVIDED FOR IN BOOKS OF ACCOUNTS
Claims upon the company to the tune of Rs.35.124 Millions made by Central Excise Authorities are being agitated at different levels of appellate Authorities on Balance Sheet date. In addition to this there could be further demand from Central Excise to the tune of Rs.0.683 Million figuring in department s Audit Objection for which company has yet not received any Show Cause Notice from the Central Excise Department
(Rs.
In Millions)
|
Particular |
31.03.2011 |
31.03.2010 |
|
Guarantees given by bank outstanding |
15.116 |
15.853 |
|
Letters of Credit unpaid greading |
3.841 |
11.431 |
BANKERS CHARGES
REPORT AS PER REGISTRY
|
Corporate
identity number of the company |
U24100MH1982PCL027493 |
|
Name of the
company |
NEON LABORATORIES LIMITED |
|
Address of the
registered office or of the principal place of business in |
140, Damji Shamji Industrial Complex, Mahakali Caves Road, Andheri,
Mumbai- 400093, Maharashtra, India |
|
This form is for |
Modification
of charge |
|
Charge identification
(ID) number of the charge to be modified |
90188700 |
|
Type of charge |
|
|
Particular of
charge holder |
State Bank of |
|
Nature of
instrument creating charge |
a)supplementary agreement of loan for increase in the overall limit form (c.a.1) b)supplemental agreement of hypothecation of goods and assets for increase in the overall limit (c.2.a) c)letter regarding the grant of individual limit within the overall limit (c.5) all the above agreements constitute a single modification. |
|
Date of
instrument Creating the charge |
31.12.2011 |
|
Amount secured by
the charge |
Rs.960.000 |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of interest DCC 500.000 Millions 3.75% ABOVE BASE RATE ADHOC CC 50.000 Millions 4.75% ABOVE BASE RATE Terms of repayment AS PER SANCTION TERMS Margin RAW MATERIAL 25% STOCK IN PROCESS 40% PACKING MATERIALS 40% FINISHED GOODS 33.33% BOOK DEBTS/RECEIVABLES 50% Extent and
operation of the charge DCC 500.000 Millions ADHOC CC 50.000 Millions EPC (WITHIN DCC) (20.000) Millions EBD (WITHIN EPC) (20.000) Millions CORPORATE LOAN 300.000 Millions LC 70.000 Millions BUYERS CREDIT WITHIN LC(35.000) Millions BG 40.000 Millions TOTAL 960.000 Millions |
|
Short particulars
of the property or asset(s) charged (including complete address and location
of the property) |
A first charge by way of hypothecation of the borrowers entire goods, movables and other assets present and future including documents of title to goods and other assets such as book debts of customs/excise duties under the duty drawback credit scheme or any other scheme bills ,invoices, documents, contracts, contracts, insurance policies, gurantees, engagements, securities investments and of customs/excise duties under the duty drawback credit scheme, or any other scheme bills invoices, documents, contracts, insurance policies, gurantees, engagements, securities investments and rights uncalled capital and all machinery present and future of such form satisfactory to the bank. |
|
Date of
instrument modifying the charge |
30.08.2011 |
|
Particulars of
the present modification |
Now by this present modification the overall limit increased from Rs.910.000 Millions to Rs.960.000 Millions. |
FIXED ASSETS:
·
·
·
Residential Flat
·
·
·
·
Furniture and Fixture
·
Plant and Machinery
·
Material Handling and
Laboratory Equipments
·
Temperature Control
Equipment
·
Boiler
·
Office Equipment
·
Electrical Installation
·
Blocks and Dyes
·
Computer
·
Vehicles
·
Commercial Vehicle
·
Energy Saving Device
·
Shops
·
Water Purifing System
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or investigation
registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.16 |
|
|
1 |
Rs.81.80 |
|
Euro |
1 |
Rs.68.34 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
60 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.